OTCMKTS:REMI

Remedent (REMI) Stock Price, News & Analysis

$0.06
0.00 (0.00%)
(As of 04/25/2024 ET)
Today's Range
$0.06
$0.06
50-Day Range
$0.04
$0.08
52-Week Range
$0.00
$0.17
Volume
N/A
Average Volume
150 shs
Market Capitalization
$1.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
REMI stock logo

About Remedent Stock (OTCMKTS:REMI)

Remedent, Inc. researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products in the United States and internationally. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company also offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. In addition, it provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient's teeth. Further, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice that enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Additionally, it provides dental implant solutions and treatment concepts. The company sells its products through internal sales force and third party distributors. Remedent, Inc. was incorporated in 1986 and is headquartered in Ghent, Belgium.

REMI Stock Price History

REMI Stock News Headlines

REMYY Rémy Cointreau SA
Peterson Remy
The Best AI Stock to Own in the World Today is Trading for Just $25
“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.
Remedent, Inc. (REMI)
Remedent Inc.
See More Headlines
Receive REMI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Remedent and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/26/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Dental equipment & supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:REMI
Employees
3
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$1.10 million
Optionable
Not Optionable
Beta
-0.24
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Guy De Vreese (Age 69)
    Chairman & CEO
  • Mr. Philippe Van Acker (Age 59)
    CFO, Chief Accounting Officer & Director
    Comp: $188.01k

REMI Stock Analysis - Frequently Asked Questions

How have REMI shares performed in 2024?

Remedent's stock was trading at $0.0970 at the beginning of the year. Since then, REMI shares have decreased by 43.3% and is now trading at $0.0550.
View the best growth stocks for 2024 here
.

What other stocks do shareholders of Remedent own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Remedent investors own include CoStar Group (CSGP), Enterprise Products Partners (EPD), Kellanova (K), MKS Instruments (MKSI), M&T Bank (MTB), Old Line Bancshares (OLBK), RH (RH), AT&T (T), Taiwan Semiconductor Manufacturing (TSM) and

How do I buy shares of Remedent?

Shares of REMI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:REMI) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners